Select Page
A Look Back: Marijuana In 2014

A Look Back: Marijuana In 2014

2014 marked one of the most historically significant years for cannabis legislation since Nixon signed the Controlled Substances Act of 1970. The wheels of the legislative process are slowly turning, and laws are starting to reflect the views of the growing majority of marijuana supporters in the United States. This infographic takes a close look at the changing tides of legislation and the rapidly shifting social perceptions of marijuana in 2014.

marijuana stats 2014

Yes, last year was a good year for cannabis proponents. Although Federal prohibition on marijuana remains in tact for the foreseeable future, the attacks on medical marijuana growers and providers were officially put to a halt this year. Now, almost half of the country allows some form of medical marijuana and 2 more states (and the District of Colombia) have decided that the use of marijuana should be legal for adults. Cities like Philadelphia, Houston, and Cincinnati are lessening penalties for possession in an effort to quell the harsh and unjust racial disparity in marijuana related arrests.

The 2014 midterm elections went favorably for marijuana proponents. A strong showing of support in Oregon and Alaska changed marijuana laws and DC overwhelmingly passed their initiative to legalize marijuana. Florida voters showed up to polls with 58% supporting the legalization of medical marijuana, but Florida laws say that 60% of the vote is needed to pass constitutional amendments.

Meanwhile, Colorado and Washington underwent their first year of legalization without any major calamities. Money is now filtering into state treasuries and crime rates in Colorado were down at the 6 month mark. Colorado recreational shops opened in January and combined with medical sales, brought in $60 Million in tax revenue by October. Washington recreational sales opened up on July 8 and raked in about $15 million in the first 6 months of the program. While it may take a few years to get the kinks worked out, the sky has yet to fall from the so-called ‘social experiment’ with legalized marijuana.

Beyond tax dollars and new legislation, leading voices in our country are now becoming more friendly with marijuana. From President Obama’s straightforward talk on pot to the grandparents lighting up for the first time, it seems that American society is reconsidering how they think about marijuana. Even the New York Times boldly chimed in with a plea to change our National drug policy.

The future is undeniably bright for cannabis in the United states. One estimate projects that the cannabis industry could reach a whopping 10 Billion dollars by 2018. Money spent on marijuana is now being channeled into schools and research, rather than the pockets of Mexican cartels. As proponents for legalization march onward toward 2016, the next 2 years will set the stage for the future of cannabis in America.

$8 Million For Marijuana Research Grants in CO

$8 Million For Marijuana Research Grants in CO

In a regular scheduled meeting held late last week the Colorado Medical Marijuana Scientific Advisory Council, chose eight research grant proposals for the Board of Health to consider for approval at its Dec. 17 meeting. Proposed studies are wide ranging and focused on targeting specific diseases and groups of people.

“Colorado is leading the way in devoting significant resources to study medical marijuana,” said Dr. Larry Wolk, executive director and chief medical officer at the Colorado Department of Public Health and Environment. “We hope the studies will contribute to the scientific research available about the use of marijuana in effectively treating various medical conditions.”

In 2013 during the formation of Amendment 64, the Colorado General Assembly (SB14-155) formed an advisory council and appropriated $10 million from the medical marijuana cash fund to be used for “objective scientific research regarding the efficacy of marijuana and its component parts as part of medical treatment.” It’s important to note $1 million of the total $10 million is to be used for costs to administer the program.

The advisory council reviewed a total of 57 proposals, 10 of which didn’t meet initial requirements. Of the 47 remaining proposals, the eight list below have made the ‘final cut.’ Each of the proposals is a 2-3 year study. In the event there is unallocated funding, the board may dictate the department and advisory council regarding the funding of additional research proposals.

Applicant:
University of Colorado Denver Anschutz Medical Campus
Project:
Do Adolescents and Young Adults with Inflammatory Bowel Disease Benefit from Use of Marijuana?
Primary Investigator:
Edward J. Hoffenberg, University of Colorado Denver School of Medicine, Children’s Hospital Colorado
Grant Amount:
$1,191,329.00

Applicant:
University of Colorado Denver Anschutz Medical Campus
Project:
A Randomized, Double-blind, Placebo-controlled Crossover Study of Tolerability and Efficacy of Cannabidiol (CBD) on Tremor in Parkinson’s Disease
Primary Investigator:
Maureen A. Leehey, Department of Neurology, University of Colorado
Grant Amount:
$831,801.00

Applicant:
University of Pennsylvania School of Medicine
Project:
Treating PTSD with Marijuana: Clinical and Functional Outcomes
Primary Investigator:
Marcel O. Bonn-Miller, Dept. of Psychiatry, University of Pennsylvania, and VA National Center for PTSD
Grant Amount:
$1,100,040.00

Applicant:
University of Colorado Denver Anschutz Medical Campus
Project:
Cannabidiol (CBD) and Pediatric Epilepsy
Primary Investigator:
George Sam Wang, Department of Pediatrics, University of Colorado and Children’s Hospital Colorado
Grant Amount:
$523,955.29

Applicant:
University of Colorado Denver Anschutz Medical Campus
Project:
Medical Marijuana in the Pediatric Brain Tumor Population(palliative care)
Primary Investigator:
Nicholas Foreman, Dept. of Pediatrics, Pediatric Neuro-oncology, Children’s Hospital Colorado
Grant Amount:
$1,041,256.00

Applicant:
University of Colorado Denver Anschutz Medical Campus
Project:
Use of Medicinal Cannabinoids as Adjunctive Treatment for Medically Refractory Epilepsy (pediatric epilepsy)
Primary Investigator:
Kelly Knupp, Dept. of Pediatrics, Children’s Hospital Colorado and University of Colorado School of Medicine
Grant Amount:
$472,577.00

Applicant:
Multidisciplinary Association for Psychedelic Studies
Project:
Placebo-controlled, Triple-Blind, Randomized Crossover Pilot Study of the Safety and Efficacy of Four Potencies of Smoked Marijuana in 76 Veterans with Chronic, Treatment- Resistant Post Traumatic Stress Disorder (PTSD)
Primary Investigator:
Marcel O. Bonn-Miller, University of Pennsylvania and VA National Center for PTSD
Grant Amount:
$2,000,000.00

Applicant:
University of Colorado Denver Anschutz Medical Campus
Project:
A Double Blind, Placebo-Controlled Cross Study Comparing the Analgesic Efficacy of Cannabis versus Oxycodone
Primary Investigator:
Emily Lindley, Dept. of Orthopedics, University of Colorado
Grant Amount:
$472,398.10

Total: $7,633,356.39

Subscribe To Our Newsletter

Join our mailing list to receive the latest news and updates from our team.

You have Successfully Subscribed!

[data-image-id='gourmet_bg']
[data-image-id='gourmet_bg']
[data-image-id='gourmet_bg']
[data-image-id='gourmet_bg']
[data-image-id='gourmet_bg']
[data-image-id='gourmet_bg']
[data-image-id='gourmet']
[data-image-id='gourmet']
[data-image-id='gourmet']
[data-image-id='gourmet']
[data-image-id='gourmet']
[data-image-id='gourmet']
[data-image-id='gourmet']
[data-image-id='gourmet']
[data-image-id='gourmet']
[data-image-id='gourmet']